DOI QR코드

DOI QR Code

Anti-cancer Effects of Sargassum micracanthum Extract on Non-small Cell Lung Cancer Cells

잔가시모자반 추출물의 비소세포폐암 세포주에 대한 항암효과

  • Hyun-Ji Park (Department of Pathology, College of Korean Medicine, Dong-eui University) ;
  • Seon-Eun Park (Department of Pathology, College of Korean Medicine, Dong-eui University) ;
  • Gyoo-Yong Chi (Department of Pathology, College of Korean Medicine, Dong-eui University) ;
  • Yung-Hyun Choi (Department of Biochemistry, College of Korean Medicine, Dong-eui University) ;
  • Shin-Hyung Park (Department of Pathology, College of Korean Medicine, Dong-eui University)
  • 박현지 (동의대학교 한의과대학 병리학교실) ;
  • 박선은 (동의대학교 한의과대학 병리학교실) ;
  • 지규용 (동의대학교 한의과대학 병리학교실) ;
  • 최영현 (동의대학교 한의과대학 생화학교실) ;
  • 박신형 (동의대학교 한의과대학 병리학교실)
  • Received : 2025.07.21
  • Accepted : 2025.08.20
  • Published : 2025.10.25

Abstract

Sargassum micracanthum (SM), a brown macroalga widely distributed along the Korean coastline, is known for its diverse pharmacological activities, including anti-inflammatory, antioxidant, and anticancer effects. While its ability to inhibit the migration and invasion of head and neck cancer cells has been reported, its cytotoxic activity against non-small cell lung cancer (NSCLC) cells remains largely unexplored. In this study, we evaluated the anticancer effects of an ethanolic extract of SM (ESM) on NSCLC cells, focusing on apoptosis induction. ESM significantly reduced the viability of H1299, PC9, and H1975 human NSCLC cells in a dose- and time-dependent manner. Treatment with ESM increased the sub-G1 cell population, annexin V-positive cells, and apoptotic nuclear condensation in a concentration-dependent fashion. ESM also upregulated cleaved PARP expression across all tested cell lines. Collectively, these findings indicate that ESM exerts anticancer effects in NSCLC cells by promoting apoptosis, highlighting its potential as a natural source for novel therapeutic agents against NSCLC.

Keywords

Acknowledgement

본 논문은 2024학년도 동의대학교 연구년 지원 및 동의대학교 교내특별연구과제 지원(과제번호 202500620001)에 의해 연구되었음.

References

  1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J. Clin. 2024;74(1):12-49. doi:10.3322/caac.21820. Erratum in: CA Cancer J. Clin. 2024;74(2):203. doi: 10.3322/caac.21830.
  2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71(3):209-49. doi:10.3322/caac.21660.
  3. Jeon DS, Kim HC, Kim SH, Kim TJ, Kim HK, Moon MH, Beck KS, Suh YG, Song C, Ahn JS, Lee JE, Lim JU, Jeon JH, Jung KW, Jung CY, Cho JS, Choi YD, Hwang SS, Choi CM. Five-year overall survival and prognostic factors in patients with lung cancer: results from the Korean Association of Lung Cancer Registry (KALC-R) 2015. Cancer Res. Treat. 2023;55(1):103-11. doi:10.4143/crt.2022.264.
  4. Inamura K. Lung cancer: understanding its molecular pathology and the 2015 WHO classification. Front. Oncol. 2017;7:193. doi: 10.3389/fonc.2017.00193.
  5. Bouchard N, Daaboul N. Lung cancer: targeted therapy in 2025. Curr. Oncol. 2025;32(3):146. doi:10.3390/curroncol32030146.
  6. Mountzios G. Immunotherapy with or without chemotherapy in advanced NSCLC—a delicate balance of harm and benefit. JAMA Oncol. 2025. doi:10.1001/jamaoncol.2025.0897.
  7. Koulouris A, Tsagkaris C, Corriero AC, Metro G, Mountzios G. Resistance to TKIs in EGFR-mutated non-small cell lung cancer: from mechanisms to new therapeutic strategies. Cancers (Basel). 2022;14(14):3337. doi: 10.3390/cancers14143337.
  8. Zhou K, Li S, Zhao Y, Cheng K. Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer. Front. Immunol. 2023;14:1127071. doi: 10.3389/fimmu.2023.1127071.
  9. Wen T, Song L, Hua S. Perspectives and controversies regarding the use of natural products for the treatment of lung cancer. Cancer Med. 2021;10(7):2396-422. doi:10.1002/cam4.3660.
  10. Yang Y, Li N, Wang TM, Di L. Natural products with activity against lung cancer: a review focusing on the tumor microenvironment. Int. J. Mol. Sci. 2021;22(19):10827. doi: 10.3390/ijms221910827.
  11. Memarzia A, Saadat S, Asgharzadeh F, Behrouz S, Folkerts G, Boskabady MH. Therapeutic effects of medicinal plants and their constituents on lung cancer, in vitro, in vivo and clinical evidence. J. Cell Mol. Med. 2023;27(19):2841-63. doi: 10.1111/jcmm.17936.
  12. Siddiquee T, Bhaskaran NA, Nathani K, Sawarkar SP. Empowering lung cancer treatment: harnessing the potential of natural phytoconstituent-loaded nanoparticles. Phytother. Res. 2024;38(8):3899-920. doi:10.1002/ptr.8241.
  13. Zhuang Z, Chen Q, Zhong X, Chen H, Yu R, Tang Y. Ginsenoside Rg3, a promising agent for NSCLC patients in the pandemic: a large-scale data mining and systemic biological analysis. J. Ginseng Res. 2023;47(2):291-301. doi: 10.1016/j.jgr.2022.09.006.
  14. Yu H, Zhang Q, Farooqi AA, Wang J, Yue Y, Geng L, Wu N. Opportunities and challenges of fucoidan for tumors therapy. Carbohydr. Polym. 2024;324:121555. doi: 10.1016/j.carbpol.2023.121555.
  15. Liu TC, Shih CJ, Chiou YL. Oral administration of oligo fucoidan improves the survival rate, quality of life, and immunity in patients with lung cancer. Food Nutr. Res. 2024;68. doi: 10.29219/fnr.v68.10674.
  16. Mei C, Zhou S, Zhu L, Ming J, Zeng F, Xu R. Antitumor effects of Laminaria extract fucoxanthin on lung cancer. Mar. Drugs. 2017;15(2):39. doi: 10.3390/md15020039.
  17. Hao S, Yan Y, Li S, Zhao L, Zhang C, Liu L, Wang C. The in vitro anti-tumor activity of phycocyanin against non-small cell lung cancer cells. Mar. Drugs. 2018;16(6):178. doi: 10.3390/md16060178.
  18. Ham YM, Yoon WJ, Lee WJ, Kim SC, Baik JS, Kim JH, Lee GS, Lee NH, Hyun CG Anti-inflammatory effects of isoketocharbroic acid from brown alga, Sargassum micracanthum. EXCLI J. 2015;14:1116-21. doi:10.17179/excli2015-555.
  19. Kim C, Lee IK, Cho GY, Oh KH, Lim YW, Yun BS Sargassumol, a novel antioxidant from the brown alga Sargassum micracanthum. J. Antibiot (Tokyo). 2012;65(2):87-9. doi: 10.1038/ja.2011.107.
  20. Ahn MH, Shin JA, Yang SO, Choi WS, Jang S, Kang SC, Cho SD Metabolite profiling of a Sargassum micracanthum methanol extract with in vitro efficacy against human head and neck squamous cell carcinoma aggressiveness. Arch. Oral Biol. 2022;137:105386. doi:10.1016/j.archoralbio.2022.105386.
  21. Rai Y, Pathak R, Kumari N, Sah DK, Pandey S, Kalra N, Soni R, Dwarakanath BS, Bhatt AN Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition. Sci. Rep. 2018;8(1):1531. doi:10.1038/s41598-018-19930-w.
  22. Lakshmanan I, Batra SK Protocol for Apoptosis Assay by Flow Cytometry Using Annexin V Staining Method. Bio Protoc. 2013;3(6):e374. doi: 10.21769/bioprotoc.374.
  23. Riccardi C, Nicoletti I Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat. Protoc. 2006;1(3):1458-61. doi: 10.1038/nprot.2006.238.
  24. Archana M, Bastian, Yogesh TL, Kumaraswamy KL Various methods available for detection of apoptotic cells--a review. Indian J. Cancer. 2013;50(3):274-83. doi:10.4103/0019-509X.118720.
  25. Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, Smulson M Role of poly(ADP-ribose)polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J. Biol. Chem. 1999;274(33):22932-40. doi: 10.1074/jbc.274.33.22932.
  26. Ministry of Food and Drug Safety Korean Herbal Pharmacopoeia (Herbal Medicine Standards). Ministry of Food and Drug Safety, Republic of Korea; 2023.
  27. The Jointly Published Textbook Compilation Committee of Oriental College of Medicine Nationwide Department Herbology. Seoul: Younglim Press; 2004.
  28. Mori J, Iwashima M, Wakasugi H, Saito H, Matsunaga T, Ogasawara M, Takahashi S, Suzuki H, Hayashi T New plastoquinones isolated from the brown alga, Sargassum micracanthum. Chem. Pharm. Bull. (Tokyo). 2005;53(9):1159-63. doi: 10.1248/cpb.53.1159.
  29. Mori J, Hayashi T, Iwashima M, Matsunaga T, Saito H Effects of plastoquinones from the brown alga Sargassum micracanthum and a new chromene derivative converted from the plastoquinones on acute gastric lesions in rats. Biol. Pharm. Bull. 2006;29(6):1197-201. doi: 10.1248/bpb.29.1197.
  30. Kim JY, Lee JM, Kim HS, Ki DW, Yim MJ, Ko SC, Shin JM, Lee MS, Park YG, Lee DS. A new Butenolide Derivative from the Brown Alga Sargassum micracanthum. Nat. Prod. Commun. 2022;17(1):1934578X2110686. doi:10.1177/1934578X211068606.
  31. Bae H, Lee JY, Song G, Lim W Fucosterol suppresses the progression of human ovarian cancer by inducing mitochondrial dysfunction and endoplasmic reticulum stress. Mar. Drugs. 2020;18(5):261. doi: 10.3390/md18050261.
  32. Ji YB, Ji CF, Yue L Study on human promyelocytic leukemia HL-60 cells apoptosis induced by fucosterol. Biomed. Mater. Eng. 2014;24(1):845-51. doi:10.3233/BME-130876.
  33. Mao Z, Shen X, Dong P, Liu G, Pan S, Sun X, Hu H, Pan L, Huang J Fucosterol exerts antiproliferative effects on human lung cancer cells by inducing apoptosis, cell cycle arrest and targeting of Raf/MEK/ERK signalling pathway. Phytomedicine. 2019;61:152809. doi: 10.1016/j.phymed.2018.12.032.
  34. Park HJ, Park SH The ethanolic extract of Dictyopteris divaricata induces apoptosis in non-small cell lung cancer cells by inhibiting STAT3 activity. Nutr. Cancer. 2024;76(3):305-15. doi: 10.1080/01635581.2024.2301795.
  35. Ciftci H, Sever B, Bayrak N, Yıldız M, Yıldırım H, Tateishi H, Otsuka M, Fujita M, TuYuN AF In vitro cytotoxicity evaluation of plastoquinone analogues against colorectal and breast cancers along with in silico insights. Pharmaceuticals (Basel). 2022;15(10):1266. doi: 10.3390/ph15101266.
  36. Santos-Pirath IM, Walter LO, Maioral MF, Philippus AC, Zatelli GA, Horta PA, Colepicolo P, Falkenberg MB, Santos-Silva MC Apoptotic events induced by a natural plastoquinone from the marine alga Desmarestia menziesii in lymphoid neoplasms. Exp. Hematol. 2020;86:67-77.e2. doi: 10.1016/j.exphem.2020.05.003.
  37. Mohamed HM A comprehensive review on chromene derivatives: potent anti-cancer drug development and therapeutic potential. Orient. J. Chem. 2025;41(2). doi: http://dx.doi.org/10.13005/ojc/410229.